Exciting times for cytomegalovirus (CMV) vaccine development: Navigating the pathways toward the goal of protecting infants against congenital CMV infection

Mark R. Schleiss, Don J. Diamond

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Article number526
Pages (from-to)1-4
Number of pages4
Issue number3
StatePublished - Sep 2020

Bibliographical note

Funding Information:
Funding: Support for Mark R. Schleiss from R01 HD098866 and R01 HD079918. Don J. Diamond is partially supported by NIH-U19 AI128913, NIH-P01 CA111412, and NIH-R01 CA181045. This work was also supported by the University of South Carolina’s Disability Research and Dissemination Center (DRDC) through its Cooperative Agreement (Number 6U19DD001218) with the Centers for Disease Control and Prevention (CDC).

Cite this